Cardioprotection is a well-established term in the scientific world. It describes the protection
of various mediators on the cardiovascular system. These protective effects can also be …

Although research on high-density lipoprotein (HDL) has historically focused on
atherosclerotic coronary disease, there exists untapped potential of HDL biology for the …

Background Inflammation and protein energy malnutrition are associated with heart failure
(HF) mortality. The metabolic vulnerability index (MVX) is derived from markers of …

Aim Although lipoproteins are well‐established risk factors for cardiovascular disease (CVD)
mortality, conventional measurements failed to identify lipoprotein particle sizes. This study …

Abstract HDL-Cholesterol (HDL-C) is not an accurate surrogate marker to measure the
cardioprotective functions of HDL in coronary artery diseases (CAD) patients. Hence …

Evidence regarding any association of HDL-particle (HDL-P) derangements and HDL-
cholesterol content with cardiovascular (CV) death in chronic heart failure (HF) is lacking. To …

Background: Circulating high-density lipoprotein particle (HDL-P) subfractions impact
atherogenesis, inflammation, and endothelial function, all of which are implicated in the …

Aims Acute heart failure (AHF) is typified by inflammatory and oxidative stress responses,
which are associated with unfavorable patient outcomes. Given the anti-inflammatory and …

Heart failure (HF) is closely linked to platelet counts and lipid levels. The platelet-to-high-
density lipoprotein cholesterol ratio (PHR) is a novel marker for assessing cardiovascular …

The prognostic value of the subset of high-density lipoprotein (HDL) particles containing
apolipoprotein (apo) A-II (HDL-apoA-II) in acute heart failure (AHF) remains unexplored. In …